01 5McCarthy Tétrault
01 12239448
02 12381770
03 12481207
04 12607147
05 12770851
01 5Ipilimumab
01 5Liquid
01 22016-12-04
02 12020-08-24
03 12023-04-11
04 12026-05-02
Patent Expiration Date : 2016-12-04
Date Granted : 2013-10-01
Brand Name : YERVOY
Patent Number : 2239448
Filing Date : 1996-12-04
Strength per Unit : 5 mg / mL
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2016-12-04
Date Granted : 2013-10-01
Patent Expiration Date : 2016-12-04
Date Granted : 2013-09-24
Brand Name : YERVOY
Patent Number : 2770851
Filing Date : 1996-12-04
Strength per Unit : 5 mg / mL
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2016-12-04
Date Granted : 2013-09-24
Patent Expiration Date : 2020-08-24
Date Granted : 2007-08-07
Brand Name : YERVOY
Patent Number : 2381770
Filing Date : 2000-08-24
Strength per Unit : 5 mg / mL
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2020-08-24
Date Granted : 2007-08-07
Patent Expiration Date : 2023-04-11
Date Granted : 2015-06-30
Brand Name : YERVOY
Patent Number : 2481207
Filing Date : 2003-04-11
Strength per Unit : 5 mg / mL
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2023-04-11
Date Granted : 2015-06-30
Patent Expiration Date : 2026-05-02
Date Granted : 2018-07-17
Brand Name : YERVOY
Patent Number : 2607147
Filing Date : 2006-05-02
Strength per Unit : 5 mg / mL
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2026-05-02
Date Granted : 2018-07-17
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
